Back to search

EVALUATION OF TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN MALIGNANT MESOTHELIOMA

Data up to Jan 2025

Published1997
Citations81
References26

Total Citations Per Year

Abstract

References (26)

Tumor Angiogenesis and Metastasis — Correlation in Invasive Breast Carcinoma

1991 • 5,657 citations

Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis.

1995 • 3,139 citations

Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

1991 • 2,774 citations

Induction of angiogenesis during the transition from hyperplasia to neoplasia

1989 • 1,912 citations

Control of Angiogenesis in Fibroblasts by p53 Regulation of Thrombospondin-1

1994 • 1,460 citations

Molecular mechanisms of angiogenesis: fibroblast growth factor signal transduction

1995 • 461 citations

Mutant p53 potentiates protein kinase C induction of vascular endothelial growth factor expression.

1994 • 453 citations

Clinical importance of the determination of tumor angiogenesis in breast carcinoma: much more than a new prognostic tool.

1995 • 441 citations

Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro.

1994 • 297 citations

Assessment of angiogenesis in breast carcinoma: An important factor in prognosis?

1995 • 152 citations

Hematopoietic growth factors secreted by seven human pleural mesothelioma cell lines: Interleukin‐6 production as a common feature

1992 • 132 citations

WT1 MUTATION IN MALIGNANT MESOTHELIOMA AND WT1 IMMUNOREACTIVITY IN RELATION TOp53 AND GROWTH FACTOR RECEPTOR EXPRESSION, CELL-TYPE TRANSITION, AND PROGNOSIS

1997 • 120 citations

MALIGNANT MESOTHELIOMA

1992 • 100 citations

EXPRESSION OF PLATELET-DERIVED GROWTH FACTOR (PDGF) AND PDGF RECEPTORS IN HUMAN MALIGNANT MESOTHELIOMAIN VITRO ANDIN VIVO

1996 • 93 citations

Normal human mesothelial cells and mesothelioma cell lines express insulin-like growth factor I and associated molecules.

1993 • 87 citations

Microvessel quantification in primary colorectal carcinoma: an immunohistochemical study

1995 • 80 citations

Intrapleural production of interleukin 6 during mesothelioma and its modulation by gamma-interferon treatment.

1994 • 66 citations

Patho- and immunobiology of malignant mesothelioma: characterisation of tumour infiltrating leucocytes and cytokine production in a murine model

1994 • 54 citations

Correlation of Intratumoral Microvessel Density and p53 Protein Overexpression in Human Colorectal Adenocarcinoma

1996 • 49 citations

Malignant Pleural Mesothelioma: Some Aspects of Epidemiology, Differential Diagnosis and Prognosis

1990 • 39 citations

Angiogenesis in Mesotheliomas

1996 • 35 citations

Immunoreactivity for p53 and mdm2 and the detection of p53 mutations in human malignant mesothelioma

1995 • 31 citations

Proliferation in malignant mesothelioma as determined by mitosis counts and immunoreactivity for proliferating cell nuclear antigen (PCNA)

1994 • 27 citations

Induction of angiogenesis by intraperitoneal injection of asbestos fibers

1989 • 26 citations

Diffuse malignant mesothelioma of the pleura: A clinicopathological study of six patients with a prolonged symptom-free interval or extended survival after biopsy and a review of the literature of long-term survival

1993 • 21 citations

Comparison of silver-staining nucleolar organizer region (AgNOR) counts and proliferating cell nuclear antigen (PCNA) expression in reactive mesothelial hyperplasia and malignant mesothelioma

1995 • 18 citations

Cited By (0)

No citing papers found in database

EVALUATION OF TUMOUR ANGIOGENESIS AS A PROGNOSTIC MARKER IN MALIGNANT MESOTHELIOMA (1997) – The Journal of Pathology | Metascience Observatory Explorer